Journal Publications
Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.
Author(s) |
Date | Article Title | Journal |
|---|---|---|---|
|
Khaled El Emam, Lucy Mosquera, Chaoyi Zheng |
November 2020 | Optimizing the synthesis of clinical trial data using sequential trees | Journal of the American Medical Informatics Association |
|
Khaled El Emam, Lucy Mosquera, Xi Fang |
October 2022 | Validating a membership disclosure metric for synthetic health data | Jamia Open |
|
Kirill Zhudenkov, Sergey Gavrilov, Alina Sofronova, Oleg Stepanov, Nataliya Kudryashova, Gabriel Helmlinger, Kirill Peskov |
January 2022 | A workflow for the joint modeling of longitudinal and event data in the development of therapeutics: Tools, statistical methods, and diagnostics | ASCPT |
|
Kirit Singh, Kristen A. Batich, Patrick Y. Wen, Aaron C. Tan, Stephen J. Bagley, Michael Lim, Michael Platten, Howard Colman, David M. Ashley, Susan M. Chang, Rifaquat Rahman, Evanthia Galanis, Alireza Mansouri, Vinay K. Puduvalli, David A. Reardon, Solmaz Sahebjam, John H. Sampson, John Simes, Donald A. Berry, Gelareh Zadeh, Tim F. Cloughesy, Minesh P. Mehta, Steven Piantadosi,Michael Weller, Amy B. Heimberger |
September 2021 | Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma | American Association for Cancer Research |
|
Krastan B. Blagoev, Roumen Iordanov, Mengxi Zhou, Tito Fojo, Susan E. Bates |
January 2021 | Drug resistant cells with very large proliferative potential grow exponentially in metastatic prostate cancer | Oncotarget |
|
L. Du, C. Yau, L. Brown-Swigart, R. Gould, G. Krings, G. L. Hirst, I. Bedrosian, R. M. Layman, J.M. Carter, M. Klein, S. Venters, S. Sonal, M. van der Noordaa, A. J. Chien, T. Haddad, C. Isaacs, L. Pusztai, K. Albain, R. Nanda, D. Tripathy, M.C. Liu, J. Boughey, R. Schwab, N. Hylton, A.DeMichele, J. Perlmutter, D. Yee, D. Berry, L. van’t Veer, V. Valero, L. Esserman, W. F.Symmans |
February 2021 | Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2-) breast cancer prior to chemo-endocrine therapy | Annals of Oncology |
|
Leeann B Burton, Mahsa Eskian, Amanda C Guidon, Kerry L Reynolds |
November 2021 | A review of neurotoxicities associated with immunotherapy and a framework for evaluation | Neuro-Oncology Advances |
|
Liling Huang , Shiyu Jiang & Yuankai Shi |
February 2022 | Prognostic significance of baseline neutrophil–lymphocyte ratio in patients with non-small-cell lung cancer: a pooled analysis of open phase III clinical trial data | futuremedicine |
|
Lixia Wu, Lina Zhu, Kequn Xu, Siyuan Zhou, Yang Zhou, Tiening Zhang, Junjie Hang, Benny Chung-Ying Zee |
January 2021 | Clinical significance of site-specific metastases in pancreatic cancer: a study based on both clinical trial and real-world data | Journal of Cancer |
|
Louis Dron, Shirin Golchi, Grace Hsu, Kristian, Thorlund |
September 2019 | Minimizing Control Group Allocation in Randomized Trials Using Dynamic Borrowing of External Control Data – An Application to Second Line Therapy for Non-Small Cell Lung Cancer | Contemporary Clinical Trials Communications |
|
Massimiliano Zanin |
November 2017 | Using complex networks for refining survival prognosis in prostate cancer patient | F1000 Research |
|
Mehrad Mahmoudian, Fatemeh Seyednasrollah, Liisa Koivu, Outi Hirvonen, Sirkku Jyrkkio, Laura L. Elo |
May 2019 | A predictive model of overall survival in patients with metastatic castration-resistant prostate cancer | F1000 Research |
|
Mel Horwitch, Milos Milicsevics |
October 2018 | Incumbent Firm Capacity Building in Analytics: Strategy, Structure, and Innovation Management Perspectives | IEEE Journal of Biomedical and Health Informatics |
|
Michael A. Webster-Clark, Hanna K. Sanoff, Til Stürmer, Sharon Peacock Hinton, Jennifer L. Lund |
January 2019 | Diagnostic Assessment of Assumptions for External Validity - An Example Using Data in Metastatic Colorectal Cancer | Epidemiology |
